“Food, housing, materials, electronics—all will be disrupted by biology,' says Ginkgo Bioworks CEO Jason Kelly by amyfeldman
it has raised more than $400 million from investors that include Bill Gates’ Cascade Investments, Viking Global and General Atlantic. As of December 2017, it was valued at $1.4 billion. Over a decade after Ginkgo’s founding, Kelly and his cofounders all still work there and have retained stakes in the company thatestimates at more than $100 million each. Kelly figures he’ll take Ginkgo public eventually—he’s in no rush.
Knight, 71, a computer expert, had made an unusual mid-career switch. In the 1990s, he’d begun to wonder when Moore’s Law—Intel cofounder Gordon Moore’s observation that the number of transistors on a microchip doubles every two years—would end. The problem, he explains, is that structures eventually become so small that you’re working with silicon at the atomic scale, and placing atoms in the right place with precision requires biochemistry.
With an initial investment of $100,000 from Knight , the five started Ginkgo. Their timing was lousy. The financial crisis had pushed the economy into recession. Banks weren’t lending, and venture capitalists weren’t investing. And even if they were, Ginkgo wouldn’t have appealed then. “We don’t look like normal biotech founders,” Kelly says. “No one starts a biotech company out of school, we weren’t doing a therapeutic and we had no product in mind.
“The idea of using biology for industrial purposes has long been a dream,” says Josh Hoffman, CEO of Emeryville, California-based Zymergen, Ginkgo’s closest competitor. “Unless you can get it to work at scale it’s a dream with wonderful appeal, but it’s unlikely to have impact.” The automation allows Ginkgo to test thousands, or even tens of thousands, of designs on each project, Canton says, compared with a traditional lab where a bench scientist might be able to do ten. “We were inspired by what Intel and others do in building their semiconductor facilities,” he says. This winter, Ginkgo opened Bioworks 4, which will work with mammalian cells.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize ManufacturingCustomized organisms will revolutionize the way we manufacture everything. Gingko Bioworks is brewing the building blocks for our bioengineered future.
Baca lebih lajut »
Here\u2019s How 'Stranger Things' Star Joe Chrest Brought Ted Wheeler To LifeTed Wheeler, the seemingly nonchalant of Nancy, Mike and their younger sister, is played by actor Joe Chrest.
Baca lebih lajut »
Cystic Fibrosis Shortened Her Life Expectancy So She & A Friend Went In Search Of Natural HealingA new Netflix documentary follows two friends as they travel to South America to experience using ayahuasca, a traditional medicinal tea with powerful psychedelic properties, and other healthing methods.
Baca lebih lajut »
16 Taylor Swift Songs That Will Destroy Your LifeHidden on Fearless is this sleeper hit about dating a perfectly nice boy who turns out to be, well, boring as hell. Instead, an unimpressed Taylor daydreams about her ex and their batshit-cray romance of yesteryear, singing, 'I miss screaming and fighting and kissing in the rain.' 'Rollercoaster kind of rush,' indeed.
Baca lebih lajut »